Equity
€18,985 from €246,321 in 2024
Equity fell by 92% in 1 year.
KALEIDOLEX
Lifetime
4 annual accounts with figures on one time axispeak €182,641 (2024)
€166,878▼ 8.6%
peak €138,664 (2025)
€138,664▲ 4.3%
peak €246,321 (2024)
€18,985▼ 92.3%
€136,499▲ 241%
Board1 name since 2022
1 directorCharlotte GARCIA MORENO
Documentsfilings and deeds
23-06-202638 days before the deadline
2025micro format
Dividend €366,000Equity from €246,321 to €18,985Debts from €39,985 to €136,499Cash from €190,221 to €92,569
Key points
from the 2025 annual accountsTurnover
≈ €290,000 estimated
The micro format states no turnover.
Debts
€136,499 88% of the balance sheet
Suppliers 0%Taxes and wages 13%Other 87%
Of this, €22,599 falls due within a year.
Filings
4 annual accounts since 2022
The last four annual accounts were filed 36 to 127 days before the end of the period.
Starting capital
€2,000 100 shares
Position in the sector
12.2%
Lower solvency than 85% of companies in legal and accounting. Sector median 56.8% · 15,824 companies.
Checked score
94
Excellent
Financially stronger than 49% of micro companies in legal and accounting (NACE 69)
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%
The dashed line is the sector median: < 0.1% across 20,107 companies (NACE 69, micro).
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2024: < 0.1%
01-2025: < 0.1%● unchanged vs 12-2024
02-2025: < 0.1%● unchanged vs 01-2025
03-2025: < 0.1%● unchanged vs 02-2025highest value
04-2025: < 0.1%● unchanged vs 03-2025
05-2025: < 0.1%● unchanged vs 04-2025
06-2025: < 0.1%● unchanged vs 05-2025
07-2025: < 0.1%● unchanged vs 06-2025
08-2025: < 0.1%● unchanged vs 07-2025
09-2025: < 0.1%● unchanged vs 08-2025
10-2025: < 0.1%● unchanged vs 09-2025
11-2025: < 0.1%● unchanged vs 10-2025
12-2025: < 0.1%● unchanged vs 11-2025
01-2026: < 0.1%● unchanged vs 12-2025
02-2026: < 0.1%● unchanged vs 01-2026
03-2026: < 0.1%● unchanged vs 02-2026
04-2026: < 0.1%● unchanged vs 03-2026
05-2026: < 0.1%● unchanged vs 04-2026
06-2026: < 0.1%● unchanged vs 05-2026lowest value
07-2026: < 0.1%● unchanged vs 06-2026
08-2026: < 0.1%● unchanged vs 07-2026
09-2026: < 0.1%● unchanged vs 08-2026
10-2026: < 0.1%● unchanged vs 09-2026
11-2026: < 0.1%● unchanged vs 10-2026
Financial strengthStrong
Score breakdown
raises risk
Equity €18,985 (12.2% of total assets)
lowers risk
Sector: Legal and accounting activities (NACE 69)
Liquidity: current ratio 6.75, cash €92,569, halved
Size: total assets €155,484
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 69, micro). It does better than 17% of them on solvency, 92% on liquidity, 82% on profitability and 4% on growth.
The bankruptcy probability was computed on 09-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-12-2025.
Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Comparable companies, two years later
In July 2024, 7,976 companies had the same profile as KALEIDOLEX has now. Each dot stands for 20 companies, two years later.
94.3%
were still trading
1.8%
stopped another way
3.6%
went bankrupt
Another 0.3% stopped without a precise date, possibly only after those two years.
The bankruptcy probability of KALEIDOLEX itself is lower: < 0.1% within 12 months. It rests on far more data about KALEIDOLEX than the profile alone.
Test of the method
The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 7,976 companies, not a prediction for KALEIDOLEX. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit of up to €1,500 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 6.75 (7.06 in 2024), above the usual 1.5. Short-term debt is 14.5% and cash 59.5% of total assets. However, 87.8% of the assets are financed with debt and provisions.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Six signals.
lowers riskraises riskneutral
raises risk · Weak solvency compared with the sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 15% of 15824 sector peers (2025).
NBB · sector comparisonPosition among 15824 sector peers
Solvency
better than 15%
← weakest
strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 23-06-2026, 38 days ahead of the deadline.
NBB · 4 filingsDeviation from the deadline
2025
38 days early
2024
127 days early
2023
36 days early
2022
41 days early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
The company filed its last 4 accounts on average 61 days before the deadline. In the sector (NACE 69), the median for financial year 2024 was 9 days before the deadline, and 32% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 22 June (3 of the last 4 accounts filed within 30 days either side of that date).
Companies Code · seven monthsWhere today falls in the filing period
10-11-2026 today31-12-2026 year end31-07-2027 deadline
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0791633826
Incorporation
Founding capital of €2,000, 100 shares · Founder: Charlotte GARCIA MORENO · Appointment: Charlotte GARCIA MORENO (statutory director) · published on 03-10-2022 · Gazette deed
First establishment
Lindenlaan 4, Sint-Genesius-Rode
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| KALEIDOLEX Sint-Genesius-Rode | €155,484 | €166,878 | 12.2% | - |
| ATRIUM MAGNUM Mortsel | €180,431 | €165,780 | 32.7% | - |
| VDMH Advocaat Ixelles | €171,566 | €181,084 | 0.6% | - |
| VULLO - SOCIETE D'AVOCATS Liège | €156,665 | €173,565 | 79.6% | - |
| LAETITIA FILLIEUX, AVOCAT Liège | €155,803 | €143,175 | 33.1% | - |
| Cabinet J. Honoré Mons | €188,206 | €175,119 | 53.5% | - |
| DEWE LEGAL Dilbeek | €133,296 | €162,838 | 86.5% | - |
These companies have the same main activity as KALEIDOLEX: activities of lawyers (NACE 69101). They are comparable in size and age: total assets between €133,000 and €188,000, founded between 2021 and 2022.
Official details
Source: KBO- Status
- Active since 29-09-2022Normal situation
- Activity
- Activities of lawyersNACE 69101
- Establishment unit
- 2.336.448.0071640 Sint-Genesius-Rode, since 29-09-2022
- Financial year end
- 31 December
- Peppol
- Reachable since 27-03-2026
Annual accounts 2025
- €155,484▼ 45.7%
- Filing
- Filed on 23-06-2026, 38 days before the end of the filing period
Insights on KALEIDOLEX
KALEIDOLEX files the micro format. That format states no turnover. The gross margin rose from €37,468 in 2022 to €166,878 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about KALEIDOLEX
- What is the company number of KALEIDOLEX?
- The company number of KALEIDOLEX is 0791.633.826. The VAT number is the same number with BE in front: BE 0791.633.826.
- Where is KALEIDOLEX based?
- The registered office is at Lindenlaan 4, 1640 Sint-Genesius-Rode.Company details
- What does KALEIDOLEX do?
- According to the KBO register, the main activity is activities of lawyers (NACE 69101).
- What is the legal form of KALEIDOLEX?
- KALEIDOLEX is a private limited company (BV).
- When was KALEIDOLEX founded?
- KALEIDOLEX was founded on 29-09-2022.
- Is KALEIDOLEX still active?
- Yes, KALEIDOLEX is an active enterprise in the KBO register.
- What is the turnover of KALEIDOLEX?
- The turnover in financial year 2025 is ≈ €290,000. This figure is estimated from the gross margin of €166,878 and 38 comparable companies (NACE 691). It probably lies between €230,000 and €440,000.Financials
- Is KALEIDOLEX profitable?
- In financial year 2025, KALEIDOLEX made a profit of €138,664.
- Where can I find the annual accounts of KALEIDOLEX?
- KALEIDOLEX filed 4 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of KALEIDOLEX due?
- KALEIDOLEX must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.